Tyers Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tyers Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-119	Closed	-$8K	–	993
2018 Q1	$8K	Sell	119 -361	-75%	-$25.6K	﹤0.01%	965
2017 Q4	$35K	Sell	480 -345	-42%	-$28.5K	﹤0.01%	950
2017 Q3	$76K	Sell	825 -101	-11%	-$7.75K	﹤0.01%	869
2017 Q2	$61K	Sell	926 -310	-25%	-$38.4K	﹤0.01%	885
2017 Q1	$268K	Hold	1,236	–	–	0.01%	491
2016 Q4	$114K	Buy	+1,236	New	+$139K	﹤0.01%	611

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tyers Asset Management's LUMO Position: Q2 2018 in Review

Tyers Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 119 shares — an estimated $8K sold.

Tyers Asset Management first reported a position in LUMO in Q4 2016 and held it in 6 quarters. The position peaked at $268K in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Tyers Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Tyers Asset Management sold 119 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $8K.
Tyers Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Tyers Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $268K in Q1 2017.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Tyers Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.